Glycan side chains on naturally presented MHC class II ligands

Journal of Mass Spectrometry

Volumn 40, Issue 1, 2005, Pages 100-104

  Dengjel, Jörn ^a   Rammensee, Hans Georg ^a   Stevanovic, Stefan ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Electrospray mass spectrometry; Glycopeptide; In source fragmentation; MHC class II ligand; N linked glycan

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANTIGENS; DESORPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IONIZATION; MASS SPECTROMETERS; MASS SPECTROMETRY; SUGARS;

GLYCOPEPTIDES; LIGANDS; MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS; MOLECULAR CHARACTERIZATION;

BIOCOMPATIBILITY;

CD53 ANTIGEN; GLYCAN; HLA DR3 ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ARTICLE; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PURIFICATION; QUADRUPOLE TIME OF FLIGHT TANDEM MASS SPECTROMETER;

GLYCOSYLATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; LIGANDS; POLYSACCHARIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 13244283455     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.780     Document Type: Article

References (26)

1. Rock KL, York IA, Saric T, Goldberg AL. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 2002; 80: 1.
2. Villadangos JA. Presentation of antigens by MHC class II molecules: getting the most out of them. Mol. Immunol. 2001; 38: 329.
3. Skipper JC, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL, Jr, Boon T, Hunt DF, Engelhard VH. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 1996; 183: 527.
4. Schmid DG, der Mulbe FD, Fleckenstein B, Weinschenk T, Jung G. Broadband detection electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry to reveal enzymatically and chemically induced deamidation reactions within peptides. Anal. Chem. 2001; 73: 6008.
5. Meadows L, Wang W, den Haan JM, Blokland E, Reinhardus C, Drijfhout JW, Shabanowitz J, Pierce R, Agulnik AI, Bishop CE, Hunt DF, Goulmy E, Engelhard VH. The HLA-A* 0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997; 6: 273.
6. Pierce RA, Field ED, den Haan JM, Caldwell JA, White FM, Marto JA, Wang W, Frost LM, Blokland E, Reinhardus C, Shabanowitz J, Hunt DF, Goulmy E, Engelhard VH. Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J. Immunol. 1999; 163: 6360.
7. Haurum JS, Hoier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J, Neefjes J, Elliott T. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J. Exp. Med. 1999; 190: 145.
8. Zarling AL, Ficarro SB, White FM, Shabanowitz J, Hunt DF, Engelhard VH. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J. Exp. Med. 2000; 192: 1755.
9. Hanisch FG, Green BN, Bateman R, Peter-Katalinic J. Localization of O-glycosylation sites of MUC1 tandem repeats by QTOF ESI mass spectrometry. J. Mass Spectrum. 1998; 33: 358.
10. Zaia J. Mass spectrometry of oligosaccharides. Mass Spectrom. Rev. 2004; 23: 161.
11. Larsen MR, Roepstorff P. Mass spectrometric identification of proteins and characterization of their post-translational modifications in proteome analysis. Fresenius' J. Anal. Chem. 2000; 366: 677.
12. An HJ, Peavy TR, Hedrick JL, Lebrilla CB. Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal. Chem. 2003; 75: 5628.
13. Mortz E, Sareneva T, Haebel S, Julkunen I, Roepstorff P. Mass spectrometric characterization of glycosylated interferon-gamma variants separated by gel electrophoresis. Electrophoresis 1996; 17: 925.
14. Schirle M, Keilholz W, Weber B, Gouttefangeas C, Dumrese T, Becker HD, Stevanovic S, Rammensee HG. Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur. J. Immunol. 2000; 30: 2216.
15. Seeger FH, Schirle M, Keilholz W, Rammensee HG, Stevanovic S. Peptide motif of HLA-B*1510. Immunogenetics 1999; 49: 996.
16. Lampson LA, Levy R. Two populations of la-like molecules on a human B cell line. J. Immunol. 1980; 125: 293.
17. Arnott D, O'Connell KL, King KL, Stults JT. An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Anal. Biochem. 1998; 258: 1.
18. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20: 3551.
19. Settineri CA, Burlingame AL. Structural characterization of protein glycosylation using HPLC/electrospray ionization mass spectrometry and glycosidase digestion. Methods Mol. Biol. 1996; 61: 255.
20. Harvey DJ. Identification of protein-bound carbohydrates by mass spectrometry. Proteomics 2001; 1: 311.
21. Lis H, Sharon N. Protein glycosylation. Structural and functional aspects. Eur. J. Biochem. 1993; 218: 1.
22. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985; 54: 631.
23. Ritchie MA, Gill AC, Deery MJ, Lilley K. Precursor ion scanning for detection and structural characterization of heterogeneous glycopeptide mixtures. J. Am. Soc. Mass Spectrom. 2002; 13: 1065.
24. Angelisova P, Vlcek C, Stefanova I, Lipoldova M, Horejsi V. The human leucocyte surface antigen CD53 is a protein structurally similar to the CD37 and MRC OX-44 antigens. Immunogenetics 1990; 32: 281.
25. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997; 7: 473.
26. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993; 178: 27.